Medicine & Life Sciences
Inflammatory Bowel Diseases
100%
Crohn Disease
97%
Colitis
33%
Adalimumab
28%
T-Lymphocytes
27%
Pediatrics
26%
Regulatory T-Lymphocytes
17%
Inflammation
17%
Child
16%
Infliximab
16%
Lactulose
14%
Therapeutics
14%
Mesenchymal Stem Cells
13%
Fistula
12%
Sclerosing Cholangitis
12%
Rhamnose
11%
Population
10%
Adrenal Cortex Hormones
9%
Cytokines
9%
Permeability
9%
Kruppel-Like Transcription Factors
9%
Restorative Proctocolectomy
9%
Epigenomics
9%
Biological Therapy
8%
Enhancer of Zeste Homolog 2 Protein
8%
Pediatric Crohn's disease
8%
Genes
8%
Interleukin-23
8%
Macrophages
7%
Safety
7%
Pediatric ulcerative colitis
7%
Celiac Disease
7%
Microscopic Colitis
7%
Cell- and Tissue-Based Therapy
7%
Histone Methyltransferases
7%
Rectovaginal Fistula
6%
Long Noncoding RNA
6%
Lymphocyte Activation
6%
p300-CBP-associated factor
6%
Tumor Necrosis Factor-alpha
6%
Mesalamine
6%
Interleukin-12
6%
Endoscopy
6%
Immunologic Factors
6%
Th17 Cells
5%
Lymphocytes
5%
Mucous Membrane
5%
Transcription Factors
5%
Biomarkers
5%